Chemokines and their receptors: orchestrating a fine balance between health and disease

References

• Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787–793.
   PubMedGoogle Scholar
• Abdi R, Smith RN, Makhlouf L, Najafian N, Luster AD, Auchincloss H Jr, Sayegh MH. 2002. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 51:2489–2495.
   Google Scholar
• Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD. 2004. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol 172:767–775.
   PubMedGoogle Scholar
• Afford SC, Fisher NC, Neil DA, Fear J, Brun P, Hubscher SG, Adams DH. 1998. Distinct patterns of chemokine expression are associated with leucocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 186:82–89.
   PubMed Web of Science ®Google Scholar
• Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. 1997. The chemokine SDF-1 is a chemoattractant for human CD34` hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34` progenitors to peripheral blood. J Exp Med 185:11–20.
   PubMedGoogle Scholar
• Ajuebor MN, Flower RJ, Hannon R, Christie M, Bowers K, Verity A, Perretti M. 1998. Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 63:108–116.
   PubMedGoogle Scholar
• Ajuebor MN, Das AM, Virag L, Flower RJ, Szabo C, Perretti M. 1999. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 162:1685–1691.
   PubMed Web of Science ®Google Scholar
• Akashi S, Sho M, Kashizuka H, Hamada K, Ikeda N. 2005. A novel small molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection. Transplantation 80:378–384.
   Google Scholar
• Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. 1996. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955–1958.
   PubMedGoogle Scholar
• Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW, Gabuzda D. 2003. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197:1701–1707.
   PubMedGoogle Scholar
• Ansari W, Hans H, Maren M, Reinhold S. 2007. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis. Immunol Lett 110:1–5.
   PubMed Web of Science ®Google Scholar
• Arvanitakis L, Geras E, Varma A, Gershengorn MC, Cesarman E. 1997. Human herpesvirus KSHV encodes a constitutively active G protein coupled receptor linked to cell proliferation. Nature 385:347–350.
   PubMedGoogle Scholar
• Bacon KB, Szabo MC, Yssel H, Bolen JB, Schall TJ. 1996. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J Exp Med 184:873.
   Google Scholar
• Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392:565–568.
   PubMedGoogle Scholar
• Baggiolini M, Clark-Lewis I. 1992. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307:97–101.
   PubMedGoogle Scholar
• Baggiolini M, Dewbald B, Moser B. 1994. Interleukin-8 and related chemostatic cytokines: CXC and CC chemokines. Adv Immunol 55:97–197.
   PubMedGoogle Scholar
• Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: an update. Annu Rev Immunol 15:675–705.
   PubMedGoogle Scholar
• Baker MS, Chen X, Rotramel AR, Nelson JJ, Lu B, Gerard C, Kanwar Y, Kaufman DB. 2003. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients. Surgery 134:126–133.
   Google Scholar
• Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, Camps M, Rückle T, Schwarz MK, Rodríguez S, Martinez-A C, Balomenos D, Rommel C, Carrera AC. 2005. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11:933–935.
   PubMedGoogle Scholar
• Barnes PJ. 1997. Nuclear factor kappa B. Int J Biochem Cell Biol 29:867–870.
   PubMedGoogle Scholar
• Barnwell JW, Nichols ME, Rubinstein P. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 169:1795.
   PubMedGoogle Scholar
• Belperio JA, Keane MP, Burdick MD, Lynch JP III, Xue YY, Li K, Ross DJ, Strieter RM. 2002. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 169:1037–1049.
   Web of Science ®Google Scholar
• Bertini R, Allegretti M, Bizzarri C, Moriconi A, Locati M, Zampella G, Cervellera MN, Di Cioccio V, Cesta MC, Galliera E, Martinez FO, Di Bitondo R, Troiani G, Sabbatini V, D’Anniballe G, Anacardio R, Cutrin JC, Cavalieri B, Mainiero F, Strippoli R, Villa P, Di Girolamo M, Martin F, Gentile M, Santoni A, Corda D, Poli G, Mantovani A, Ghezzi P, Colotta F. 2004. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci USA 101: 11791–11796.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Oukka M, Kuchroo VK. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350.
   Google Scholar
• Biscoff SC, Brunner T, De Weck AL, Dahinden CA. 1990. Interleukin-5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 172:1577–1582.
   Google Scholar
• Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. 2006. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 112:139–149.
   PubMedGoogle Scholar
• Bleul CC, Schultze JL, Springer TA. 1998. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement. J Exp Med 187:53–62.
   PubMedGoogle Scholar
• Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101:353–363.
   PubMedGoogle Scholar
• Bokoch GM. 1995. Chemoatractant signaling and leukocyte activation. Blood 86:1649–1660.
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129–134.
   PubMed Web of Science ®Google Scholar
• Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552–2561.
   PubMed Web of Science ®Google Scholar
• Boring L, Gosling J, Cleary M, Charo IF. 1998. Decreased lesion formation in CCR2–/– mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894–897.
   PubMedGoogle Scholar
• Brady HR. 1994. Leukocyte adhesion molecules and kidney disease. Kidney Int 4:1285–1300.
   Google Scholar
• Brightling CE, Kaur D, Berger P, Morgan AJ, Wardlaw AJ, Bradding P. 2005. Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol 77:759–766.
   PubMed Web of Science ®Google Scholar
• Burger J, Kipps T. 2006. XCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761–1767.
   Google Scholar
• Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60–76.
   PubMedGoogle Scholar
• Cadene M, Boudier C, de Marcillac GD, Bieth JG. 1995. Influence of low molecular mass heparin on the kinetics of neutrophil elastase inhibition by mucus proteinase inhibitor. J Biol Chem 270:13204–13209.
   PubMedGoogle Scholar
• Campanella GSV, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD. 2006. Oligomerization of IP-10 is necessary for endothelial cell presentation and in vivo activity. J Immunol 177:6991–6998.
   Google Scholar
• Campbell JJ, Butcher EC. 2000. Chemokine in tissue specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12:336–341.
   PubMedGoogle Scholar
• Campbell JJ, Foxman EF, Butcher EC. 1997. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur J Immunol 27:2571–2578.
   Google Scholar
• Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Françon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. 2005. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11:936–943.
   Google Scholar
• Cassatella MS. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21–26.
   PubMedGoogle Scholar
• Chang M, McNinch J, Elias C, Manthey C, Grosshans D, Meng T, Boone T, Andrew D. 1997. Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J Biol Chem 272:25229–25237.
   Google Scholar
• Chapman GA, Moores KE, Gohil J, Berkhout TA, Patel L, Green P, Macphee CH, Stewart BR. 2000. The role of fractalkine in the recruitment of monocytes to the endothelium. Eur J Pharmacol 392:189–195.
   PubMed Web of Science ®Google Scholar
• Chute JP. 2006. Stem cell homing. Curr Opin Hematol 13:399–406.
   PubMedGoogle Scholar
• Cobbold S, Waldmann H. 1998. Infectious tolerance. Curr Opin Immunol 10:518–524.
   PubMedGoogle Scholar
• Collins PD, Marleau S, Griffiths DA, Jose PJ, Williams TJ. 1995. Cooperation between interleukin-5 and chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182:1169–1174.
   PubMedGoogle Scholar
• Cook DN, Beck MA, Coffiman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583–1585.
   PubMedGoogle Scholar
• Craig M, Adam F. 2000. Chemokine receptors and the role in inflammation and infectious disease. J Am Society Hematol 95:3032–3043.
   Google Scholar
• Cupedo T, Mebius RE. 2003. Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin Immunol 15:243–248.
   PubMedGoogle Scholar
• D’Apuzzo M, Rolink A, Loetscher M, Hoxie JA, Clark-Lewis I, Melchers F, Baggiolini M, Moser B. 1997. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol 27:1788–1793.
   PubMed Web of Science ®Google Scholar
• D’Souza MP, Harden VA. 1996. Chemokines and HIV-1 second receptors: confluence of two fields generates optimism in AIDS research. Nat Med 2:1293–1300.
   Google Scholar
• Das AM, Flower RJ, Perrett M. 1997. Eotaxin induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. J Immunol 159:1466–1473.
   Google Scholar
• De Clercq E. 2003. The bicyclam AMD3100 story. Nat Rev Drug Discov 2:581–587.
   Google Scholar
• De Mendonca FL, da Fonseca PC, Phillips RM, Saldanha JW, Williams TJ, Williams TJ, Pease JE. 2005. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist. J Biol Chem 280:4808–4816.
   PubMedGoogle Scholar
• De Perrot M, Sekine Y, Fischer S, Waddell TK, McRae K, Liu M, Wigle DA, Keshavjee S. 2002. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 165:211–215.
   Google Scholar
• Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O’Brien SJ. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856–1862.
   Google Scholar
• Del Prete A, Vermi W, Dander E, Otero K, Barberis L, Luini W, Bernasconi S, Sironi M, Santoro A, Garlanda C, Facchetti F, Wymann MP, Vecchi A, Hirsch E, Mantovani A, Sozzani S. 2004. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgammadeficient mice. EMBO J 23:3505–3515.
   Web of Science ®Google Scholar
• Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–666.
   PubMed Web of Science ®Google Scholar
• DeVries ME, Hosiawa KA, Cameron CM, Bosinger SE, Persad D, Kelvin AA, Coombs JC, Wang H, Zhong R, Cameron MJ, Kelvin DJ. 2003. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin Immunol 15:33–48.
   PubMedGoogle Scholar
• Dommit R. 2008. Chemokines and cytokines: a primer of cellular biology of the clinical neonatalogist. Neo Rev 9:654.
   Google Scholar
• Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673.
   PubMed Web of Science ®Google Scholar
• Dragic T, Trkola A, Thompson DA, Cormier EG, Kajumo FA, Maxwell E, Lin SW, Ying W, Smith SO, Sakmar TP, Moore JP. 2000. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci USA 97:5639–5644.
   Web of Science ®Google Scholar
• Eckmann L, Reed SL, Smith JR, Kagnoff MF. 1995. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1α. J Clin Invest 96:1269–1271.
   PubMed Web of Science ®Google Scholar
• El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Terada K, Geula C, Luster AD. 2007. CCR2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13:432–438.
   Web of Science ®Google Scholar
• Elliott SN, Wallace JL. 1998. Neutrophil-mediated gastrointestinal injury. Can J Gastroenterol 12:559–568.
   PubMedGoogle Scholar
• Feng Y, Broder CC, Kennedy PE, Berger EA. 1996. HIV-1 entry cofactor: functional cDNA cloning of e seven transmembrane, G protein-coupled receptor. Science 272:872–877.
   Web of Science ®Google Scholar
• Finkelman FD, Shea-Donohue T, Morris SC, Gildea L, Strait R, Madden KB, Schopf L, Urban JF Jr. 2004. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 201:139–155.
   PubMed Web of Science ®Google Scholar
• Fischereder M, Luckow B, Hocher B, Wuthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, Neumayer H, Krämer BK, Land W, Schlöndorff D. 2001. CC chemokine receptor 5 and renal-transplant survival. Lancet 357:1758–1761.
   PubMed Web of Science ®Google Scholar
• Fisher NC, Neil DA, Williams A, Adams DH. 1999. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemotactic protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease. Gut 45:416–420.
   Web of Science ®Google Scholar
• Fujisawa N, Hayashi S, Kurdowska A, Carr FK, Miller EJ. 1999. Inhibition of GROalpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate. Cytokine 11:231.
   PubMed Web of Science ®Google Scholar
• Furie MB, Randolph GJ. 1995. Chemokines and tissue injury. Am J Pathol 146:1287–1301.
   PubMed Web of Science ®Google Scholar
• Ganju RK, Dutt P, Wu L, Newman W, Avraham H, Avraham S, Groopman JE. 1998. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. Blood 91:791.
   Google Scholar
• Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71–82.
   PubMed Web of Science ®Google Scholar
• Gelmini S, Mangoni M, Serio M, Ramagvani P, Lazzeri E. 2008. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cell metastasis. J Endocronol Invest 31:809–819.
   Google Scholar
• Ghazal B, Stephane P. 2005. Chemokines and brain function. Current drug targets. Inflam Allergy 4:387–399.
   Google Scholar
• Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnálek P, Zádorová Z, Palmer T, Donoghue S; Natalizumab Pan-European Study Group. 2003. Natalizumab for active Crohn’s disease. N Engl J Med 348:24–32.
   PubMedGoogle Scholar
• Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE. 2004. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 172:4018–4025.
   Google Scholar
• Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW. 1997. Human macrophage derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185:1595–1604.
   PubMed Web of Science ®Google Scholar
• Gong JH, Clark-Lewis I. 1997. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MPL-lpr mouse model. J Exp Med 186:131–137.
   PubMed Web of Science ®Google Scholar
• Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH. 2003. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4:965–973.
   PubMed Web of Science ®Google Scholar
• Gracia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, Murphy PM, Luster AD. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novelchemokine with activities on monocytes, eosinophils and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and 3. J Immunol 157: 5613–5626.
   PubMed Web of Science ®Google Scholar
• Grandaliano G, Gesualdo L, Ranieri E, Monno R, Montinaro V, Marra F, Schena FP. 1996. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J Am Soc Nephrol 7:906–913.
   PubMed Web of Science ®Google Scholar
• Grewal IS, Rutledge BJ, Fiorillo JA, Gu L, Gladue RP, Flavell RA, Rollins BJ. 1997. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol 159:401–408.
   PubMed Web of Science ®Google Scholar
• Gröne HJ, Weber C, Weber KSC, Gröne EF, Rabelink T, Klier CM, Wells TNC, Proudfoot AE, Schlondorff D, Nelson PJ. 1999. Met-RANTES-reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J 13:1371–1383.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Singh JP. 1994. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J Cell Biol 127:1121.
   Web of Science ®Google Scholar
• Hamada T, Mohle R, Hesselgesser J, Hoxie J, Nachman RL, Moore MA, Rafii S. 1998. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 188:39–48.
   PubMed Web of Science ®Google Scholar
• Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 192:1515–1520.
   PubMed Web of Science ®Google Scholar
• Hancock WW, Wang L, Ye Q, Han R, Lee I. 2003. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 15:479–486.
   PubMed Web of Science ®Google Scholar
• Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56:559–564.
   PubMed Web of Science ®Google Scholar
• Harris JG, Flower RJ, Watanbe K, Tsursufugi S, Wolitzky BA, Perretti M. 1996. Relative contribution of the selectins in the neutrophil recruitment caused by the chemokine cytokine-induced neutrophil chemoattractant (CINC). Biochem Biophys Res Commun 221:692–696.
   Web of Science ®Google Scholar
• Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. 1997. IκB alpha-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J 16:4698–4707.
   PubMedGoogle Scholar
• Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu Y, Menon S, Abrams J, Handel T, Zlotnik A. 1997. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 158: 1533–1540.
   PubMed Web of Science ®Google Scholar
• Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E, Bridger G, Henson GW. 2000. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44:1667–1673.
   PubMed Web of Science ®Google Scholar
• Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, Wymann MP. 2000. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287:1049–1053.
   PubMed Web of Science ®Google Scholar
• Hjelmstrom P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69: 331–339.
   PubMed Web of Science ®Google Scholar
• Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH. 1993. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 262:1182–1184.
   Google Scholar
• Horuk R. 1994. Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 15:159–165.
   PubMed Web of Science ®Google Scholar
• Huang R, Lian JP, Robinson D, Badwey JA. 1998. Neutrophils stimulated with a variety of chemoattractants exhibit rapid activation of p21-activated kinases (Paks): separate signals are required for activation and inactivation of paks. Mol Cell Biol 18:7130.
   Web of Science ®Google Scholar
• Humbert M, Ying S, Conigan C, Menz G, Barkans J, Pfister R, Meng Q, Van Damme J, Opdenakker G, Durham SR, Kay AB. 1997. Bronchial mucosal expression of the genes encoding chemokine RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil active cytokines interleukin-5, granulocyte macrophage colony stimulating factor, and IL-13. Am J Respir Cell Mol Biol 16: 1–8.
   PubMed Web of Science ®Google Scholar
• Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. 1996. Molecular cloning of a novel T cell–directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 271:21514–21521.
   Web of Science ®Google Scholar
• Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521–530.
   PubMed Web of Science ®Google Scholar
• Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the Chemokine receptor (CCR)2. J Exp Med 192:1075–1080.
   PubMed Web of Science ®Google Scholar
• Jarmin DI, Kulmburg PA, Huber NE, Baumann G, Prieschl Strassmayr EE, Baumruker T. 1994. A transcription factor with AP3-like binding specificity mediates gene regulation after an allergic triggering with IgE and Ag in mouse mast cells. J Immunol 153:5720–5729.
   PubMed Web of Science ®Google Scholar
• Johnson Z, Kosco-Vilbois MH, Herren S, Cirillo R, Muzio V, Zaratin P, Carbonatto M, Mack M, Smailbegovic A, Rose M, Lever R, Page C, Wells TN, Proudfoot AE. 2004. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol 173:5776–5785.
   Google Scholar
• Johnson Z, Proudfoot AE, Handel TM. 2005. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 16:625–636.
   PubMed Web of Science ®Google Scholar
• Kakinuma T, Hwang ST. 2006. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79:639–651.
   PubMed Web of Science ®Google Scholar
• Kampten GT, Stafford S, Poulsen LK, Alam R. 1998. The MAP kinase ERK2 is activated through CC chemokine receptor 3 (CCR3) and is essential for eotaxin-stimulated eosinophil chemotaxis. J Allergy Exp Immunol 101:223.
   Web of Science ®Google Scholar
• Kaneider NC, Agarwal A, Leger AJ, Kuliopulos A. 2005. Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nat Med 11:661–665.
   PubMedGoogle Scholar
• Karlmark KR, Wasmuth HE, Trautwein C, Tacke F. 2008. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2:233–242.
   PubMedGoogle Scholar
• Kim CH, Pelus LM, White JR, Broxmeyer HE. 1998. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood 91:434–443.
   Google Scholar
• Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC. 2001. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 108:1331–1339.
   Web of Science ®Google Scholar
• Koch AE, Polverinim PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798.
   PubMedGoogle Scholar
• Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB, Genovese MC, Wardlaw AJ, Greenberg HB, Parker CM, Butcher EC, Andrew DP, Agace WW. 2000. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 192:761–768.
   Google Scholar
• Laing K, Secombes C. 2004. Chemokines. Dev Comp Immunol 28:443–460.
   PubMedGoogle Scholar
• Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O, Rothenberg MD, Luster AD, Hamid Q. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159:4593–4601.
   PubMed Web of Science ®Google Scholar
• Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H. 1996. Evidence of cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274:602–605.
   Web of Science ®Google Scholar
• Laudanna C, Campbell JJ, Butcher EC. 1996. Role of Rho in chemoattractant activated leukocyte adhesion through integrins. Science 271:981–983.
   PubMedGoogle Scholar
• Laurent F, Eckmann L, Savidge TC, Morgan G, Theodos C, Naciri M, Kagnoff MF. 1997. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect Immun 65:5067–5073.
   PubMedGoogle Scholar
• Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M Jr, Lifson JD, Salkowitz JR, Rodriguez B, Blauvelt A, Hartley O. 2004. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306:485–487.
   PubMed Web of Science ®Google Scholar
• Legler DF, Loetscher M, Roos RS, Clark Lewis I, Baggiolini M, Moser B. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187:655–660.
   PubMed Web of Science ®Google Scholar
• Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D. 2000. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287:1046–1049.
   Google Scholar
• Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. 1995. Human Mig chemokine: biochemical and functional characterization. J Exp Med 182:1301–1314.
   Web of Science ®Google Scholar
• Liu R, Paxton WA, Choe S, Ceradini C, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367–377.
   Google Scholar
• Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601–608.
   Google Scholar
• Lukaes NW, Streiter RM, Warmington K, Lincoln P, Cheustte SW, Kunkel SL. 1997. Differential recruitment of leukocyte population and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 158:4398–4404.
   Web of Science ®Google Scholar
• Luster AD. 1998. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445.
   PubMedGoogle Scholar
• Luster AD, Leder P. 1993. IP-10, a-C-X-C-chemokine, elicits a potent thymus dependent antitumor response in vivo. J Exp Med 178:1057–1065.
   PubMedGoogle Scholar
• Luster AD, Rothenberg ME. 1997. Role of the monocyte chemotactic protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 62:620–633.
   PubMedGoogle Scholar
• Ma Q, Jones D, Springer TA. 1999. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10:463–471.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Huang S, Tabrizi M, Bell GM. 2004. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study. Chest 126:926–934.
   PubMed Web of Science ®Google Scholar
• Mangan DF, Mergenhagen SE, Wahl SM. 1993. Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol 64:461–466.
   Google Scholar
• Mantovani A. 1999. The chemokine system: redundancy for robust outputs. Immunol Today 20:254–257.
   PubMedGoogle Scholar
• Mantovani A, Bonecchi R, Locati M. 2006. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6:907–918.
   PubMedGoogle Scholar
• Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P, Gentilini P. 1999. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29:140–148.
   PubMed Web of Science ®Google Scholar
• Mellado M, Rodriguez-Frade JM, Aragay A, del Real G, Martín AM, Vila-Coro AJ, Serrano A, Mayor FJr, Martínez- AC. 1998. The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J Immunol 161:805.
   Google Scholar
• Mezzano S, Droguett M, Burgos M, Ardiles L, Caorsi I, Egido J. 1998. In situ detection of chemokines (MCP-1, RANTES, IL-8), osteopontin, fibrogenic cytokines (PDGF, TGF-beta) and apoptotic cells in human idiopathic membranous nephropathy. J Am Soc Nephrol 9:463A.
   Google Scholar
• Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O’Connor PW; International Natalizumab Multiple Sclerosis Trial Group. 2003. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348:15–23.
   Google Scholar
• Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. 1975. Erythrocyte receptors for (Plasmodium knowlesi) malaria: duffy blood group determinants. Science. 189:561.
   Google Scholar
• Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, Rothenberg M, Luster AD, Hamid Q. 1997. Eotaxin mRNA and protein expression in chronic sinusitis and allergen induced nasal response I seasonal allergic rhinitis. Am J Respir Cell Mol Biol 17:683–690.
   Web of Science ®Google Scholar
• Moench C, Uhrig A, Lohse AW, Otto G. 2004. CC chemokine receptor 5delta32 polymorphism—a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl 10:434–439.
   PubMedGoogle Scholar
• Moore BB, Keane MP, Addison CL, Arenberg DA, Strieter RM. 1998. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Invest Med 46:113–120.
   PubMed Web of Science ®Google Scholar
• Murdoch C, Monk PN, Finn A. 1999. CXC chemokine receptor expression on human endothelial cells. Cytokine 11:704.
   PubMedGoogle Scholar
• Murphy PM. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12: 593–633.
   PubMed Web of Science ®Google Scholar
• Murphy PM. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev 7:47–64.
   PubMedGoogle Scholar
• Murphy PM. 1997. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol 34:311–318.
   Google Scholar
• Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. 2000. International union of pharmacology XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:1452–1476.
   PubMed Web of Science ®Google Scholar
• Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. 1996. Defects of B-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:636–638.
   PubMed Web of Science ®Google Scholar
• Nelken NA, Coughlin SR, Gordon D, Wilcox JN. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121–1127.
   PubMedGoogle Scholar
• Nelson PJ, Krensky AM. 1998. Chemokines, lymphocytes and viruses: what goes around, comes around. Curr Opin Immunol 10:265–270.
   PubMedGoogle Scholar
• Nelson PJ, Krensky AM. 2001. Chemokines, chemokine receptors, and allograft ejection. Immunity 14:377–386.
   PubMed Web of Science ®Google Scholar
• Nelson PJ, Ortiz BD, Pattison JM, Krensky AM. 1996. Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J Immunol 157:1139–1148.
   Web of Science ®Google Scholar
• Panes J, Granger DN. 1998. Leukocyte endothelial cell interaction, molecular mechanisms and implications in gastrointestinal diseases. Gastroenterol 114:1066–1090.
   PubMedGoogle Scholar
• Panzer U, Steinmetz OM, Paust HJ, Meyer-Schwesinger C, Peters A, Turner JE, Zahner G, Heymann F, Kurts C, Hopfer H, Helmchen U, Haag F, Schneider A, Stahl RA. 2007. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Neph 18:2071–2084.
   PubMed Web of Science ®Google Scholar
• Paxton WA, Martin SR, Tse D, O’Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA. 1996. Relative resistance to HIV-1 of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 2:412–417.
   Web of Science ®Google Scholar
• Peveri P, Walz A, Dewald B, Baggiolini M. 1988. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 167:1547–1559.
   PubMed Web of Science ®Google Scholar
• Proudfoot AE, Power CA, Hoogewerf AJ, Montjovent MO, Borlat F, Offord RE, Wells TN. 1996. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem 271:2599–2603.
   Web of Science ®Google Scholar
• Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci USA 100:1885–1890.
   PubMed Web of Science ®Google Scholar
• Quackenbush EJ, Aguirre V, Wershil BK, Gutierrez Ramos JC. 1997. Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse. J Leukocyte Biol 62:661–666.
   PubMed Web of Science ®Google Scholar
• Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 194:1541–1547.
   PubMed Web of Science ®Google Scholar
• Reynaud-Gaubert M, Marin V, Thirion X, Farnarier C, Thomas P, Badier M, Bongrand P, Giudicelli R, Fuentes P. 2002. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 21:721–730.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. 1997. Chemokines. Blood 90:909–938.
   PubMed Web of Science ®Google Scholar
• Romagnani P, Beltrame C, Annunziato F, Lasagni L, Luconi M, Galli G, Cosmi L, Maggi E, Salvadori M, Pupilli C, Serio M. 1999. Role for interactions between IP-10/MIG and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol 10:2518–2526.
   Web of Science ®Google Scholar
• Ross R. 1995. Cell biology of atherosclerosis. Ann Rev Physiol 57:791.
   PubMed Web of Science ®Google Scholar
• Rossi D, Zlotnik A. 2000. The biology of chemokines and their receptors. Ann Rev Immunonol 18:217–242.
   Google Scholar
• Rot A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 13: 291–294.
   PubMedGoogle Scholar
• Rovin BH, Tan LC. 1994. Role of protein kinase pathways in IL-1 induced chemoattractant expression by human mesangial cells. Kidney Int. 46:1059–1068.
   Web of Science ®Google Scholar
• Rovin BH, Dickerson JA, Tan LC, Fassler J. 1997. Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status. Cytokine 9:178–186.
   PubMed Web of Science ®Google Scholar
• Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA. 2003. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100: 13513–13518.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A, Mackay CR. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568–574.
   PubMedGoogle Scholar
• Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 332:722–725.
   Google Scholar
• Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, Penninger JM. 2000. Function of PI3K gamma in thymocyte development, T cell activation, and neutrophil migration. Science 287:1040–1046.
   PubMed Web of Science ®Google Scholar
• Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlöndorff D. 1993. Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-γ, tumor necrosis factor-α, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971–1978.
   PubMed Web of Science ®Google Scholar
• Savkovic S, Koutsouris A, Hecht J. 1996. Attachment of a noninvasive pathogen, enteropathogenic Escherichia coli, to cultured intestinal epithelial monolayers induces transmigration to neutrophils. Infect Immun 64:4480–4487.
   PubMed Web of Science ®Google Scholar
• Schlondorff D, Nelson PJ, Luckow B, Banas B. 1997. Chemokines and renal disease. Kidney Int 51:610–621.
   Google Scholar
• Schols D. 2006. HIV coreceptor inhibitors as novel class of anti-HIV drugs. Antiviral Res 71:216–226.
   Web of Science ®Google Scholar
• Segerer S, Nelson PJ. 2005. Chemokines in renal diseases. Scientific World J 5:835–844.
   Google Scholar
• Segerer S, Mack M, Regele H, Kerjaschki D, Schlöndorff D. 1999. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int 56:52–64.
   PubMed Web of Science ®Google Scholar
• Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K. 1999. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365:654–657.
   Google Scholar
• Shaio MF, Lin PR, Liu JY, Yang JY. 1995. Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation. Infect Immun 63:3864–3870.
   PubMed Web of Science ®Google Scholar
• Sharafeldin A, Eltayeb R, Pashenkov M, Bakhiet M. 2000. Chemokines are produced in the brain early during the course of experimental African trypanosomiasis. J Neuroimmunol 103:163–170.
   PubMed Web of Science ®Google Scholar
• Sharma M, Vohra H, Bhasin D. 2005. Enhanced proinflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica:basis of invasive disease. Parasitol 131:783–796.
   PubMed Web of Science ®Google Scholar
• Sharma M, Bhasin D, Vohra H. 2008. Differential induction of immunoregulatory circuits of phagocytic cells by Gal/Gal NAc lectin from pathogenic and non-pathogenic Entamoeba. J Clin Immunol 28:542–557.
   PubMed Web of Science ®Google Scholar
• Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE. 1990. Growth inhibition of human melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848–853.
   PubMedGoogle Scholar
• Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science. 276:276-279.
   PubMed Web of Science ®Google Scholar
• Simpson KJ, Henderson NC, Bone-Larson CL, Lukacs NW, Hogaboam CM, Kunkel SL. 2003. Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci (Lond) 104:47–63.
   PubMed Web of Science ®Google Scholar
• Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314.
   PubMed Web of Science ®Google Scholar
• Stafford S, Li H, Forsythe PA, Ryan M, Bravo R, Alam R. 1997. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effect of an anti MCP-3/FIC antibody. J Immunol 158:4953–4960.
   PubMed Web of Science ®Google Scholar
• Steinmetz OM, Stahl R, Panzer U. 2009. Chemokines and B cells in renal inflammation and allograft rejection. Fron Biosci (scholar edition) 1:13–22.
   Google Scholar
• Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270:27348.
   PubMed Web of Science ®Google Scholar
• Streiter RM, Strandiford TJ, Huffnagle GB, Colletti LM, Lukaes NW, Kunkel SL. 1996. “The good, the bad, and the ugly”: the role of chemokines in models of human disease. J Immunol 156:3583–3586.
   Web of Science ®Google Scholar
• Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD. 2003. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4:982–990.
   Web of Science ®Google Scholar
• Tan J, Zhou G. 2005. Chemokine receptors and transplantation. Cell Mol Immunol 2:343–349.
   Web of Science ®Google Scholar
• Tanabe S, Lu Z, Luo Y, Quackenbush EJ, Berman MA, Collins-Racie LA, Mi S, Reilly C, Lo D, Jacobs KA, Dorf ME. 1997. Identification of a new mouse betachemokine, thymus-derived chemotactic agent 4, with activity on T lymphocytes and mesangial cells. J Immunol 159:5671–5679.
   Web of Science ®Google Scholar
• Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ. 1996. IL-8 induced degradation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 97:1931–1941.
   PubMed Web of Science ®Google Scholar
• Thomas SY, Banerji A, Medoff BD, Lilly CM, Luster AD. 2007. Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced homing of T cells to the human asthmatic airway. J Immunol 179:1901–1912.
   Web of Science ®Google Scholar
• Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184–187.
   PubMed Web of Science ®Google Scholar
• Turner SJ, Domin J, Waterfield MD, Ward SG, Westwick J. 1998. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J Biol Chem 273:25987.
   Web of Science ®Google Scholar
• Ulbrich H, Eriksson EE, Lindbom L. 2003. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 24:640–647.
   PubMed Web of Science ®Google Scholar
• Veazey RS, Klasse PJ, Ketas TJ, Reeves JD, Piatak M Jr, Kunstman K, Kuhmann SE, Marx PA, Lifson JD, Dufour J, Mefford M, Pandrea I, Wolinsky SM, Doms RW, DeMartino JA, Siciliano SJ, Lyons K, Springer MS, Moore JP. 2003. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med 198:1551–1562.
   PubMed Web of Science ®Google Scholar
• Veazey RS, Springer MS, Marx PA, Dufour J, Klasse PJ, Moore JP. 2005. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat Med 11:1293–1294.
   Web of Science ®Google Scholar
• Verani A, Lusso P. 2002. Chemokines as Natural HIV Antagonists. Curr Mol Med 2:691–702.
   PubMedGoogle Scholar
• Vielhauer V, Anders HJ. 2009. Chemokines and chemokine receptors as therapeutic targets in chronic kidney disease. Fron Biosci 1:1–12.
   Google Scholar
• Viola A, Luster A. 2008. Chemokines and their receptors: drug targets in immunity and infection. Ann Rev Pharmacol Toxicol 48:171–197.
   PubMed Web of Science ®Google Scholar
• Volin MV, Joseph L, Shockley MS, Davies PF. 1998. Chemokine receptor CXCR4 expression in endothelium. Biochem Biophys Res Commun 242:46.
   PubMed Web of Science ®Google Scholar
• Wada T, Tomosugi N, Naito T, Yokoyama H, Kobayashi K, Harada A, Mukaida N, Matsushima K. 1994. Prevention of proteinurea by the administration of anti interleukin-8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Ed 180:1135–1140.
   Google Scholar
• Wada T, Furuichi K, Segawa-Takaeda C, Shimizu M, Sakai N, Takeda SI, Takasawa K, Kida H, Kobayashi KI, Mukaida N, Ohmoto Y, Matsushima K, Yokoyama H. 1999. MIP-1α and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 56:995–1003.
   Web of Science ®Google Scholar
• Wald O, Pappo O, Safadi R, Dagan-Berger M, Beider K, Wald H, Franitza S, Weiss I, Avniel S, Boaz P, Hanna J, Zamir G, Eid A, Mandelboim O, Spengler U, Galun E, Peled A. 2004. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol 34(4):1164–1174.
   Web of Science ®Google Scholar
• Wald O, Weiss ID, Galun E, Peled A. 2007. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics. Cytokine 39:50–62.
   PubMed Web of Science ®Google Scholar
• Wang X, Yue TL, Ohlstein EH, Sung CP, Feuerstein GZ. 1996. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem 271:24.
   Web of Science ®Google Scholar
• Ward SH, Westwick J. 1998. Chemokines: understanding their role in T-lymphocyte biology. Biochem. J. 333:457-470.
   PubMed Web of Science ®Google Scholar
• Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. 1993. Binding to eparan sulfate or heparin enhances neutrophil responses to interleukin gmas and enigmas. Nat Rev Immunol 4:360–370.
   Google Scholar
• Weber KS, von Hundelshausen P, Clark Lewis I, Weber PC, Weber C. 1999. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol 29:700–712.
   Web of Science ®Google Scholar
• Williams EJ, Haque S, Banks C, Johnson P, Sarsefield N. 2000. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J Pathol 192: 533.
   PubMed Web of Science ®Google Scholar
• Wolpe SD, Cerani A. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 3: 2565–2573.
   PubMed Web of Science ®Google Scholar
• Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179–183.
   Web of Science ®Google Scholar
• Yamauchi F, Kashem A, Endoh M, Nomoto Y, Sakai H. 1996. Detection of monocyte chemoattractant protein-1 (MCP-1) and its receptors in mesangial proliferative glomerulonephritis. Nephrology 2:93–99.
   Web of Science ®Google Scholar
• Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, Li J, Das AM, Shealy D, Griswold DE, Li L. 2004. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 28:224–232.
   Web of Science ®Google Scholar
• Yang S, Eckmann L, Panja A, Kagnoff M. 1997. Differential and regulated expression of C-X-C, C-C and C- chemokines by human colon epithelial cells. Gastroenterology 113:1214–1223.
   Web of Science ®Google Scholar
• Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. 1992. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 267:22506–22511.
   PubMed Web of Science ®Google Scholar
• Ying S, Taborda L, Meng Q, Humbert M, Kay AB. 1995. The kinetics of allergen induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 181:2153–2159.
   Web of Science ®Google Scholar
• Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, Kobayashi K, Su S, Mukaida N, Matsushima K. 1998. Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukocyte Biol 63:493–499.
   PubMed Web of Science ®Google Scholar
• Zaballos A, Gutierrez J, Varona R, Ardavin C, Marquez G. 1999. Cutting edge: identification of the orphan chemokine receptor GPR-9–6 as CCR9, the receptor for the chemokine TECK. J Immunol 162:671–675.
   PubMed Web of Science ®Google Scholar
• Zhao DX, Hu Y, Miller GG, Luster AD, Mitchell RN, Libby P. 2002. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN inducible protein 10, monokine induced by IFN, and IFN-inducible Tcell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 169:1556–1560.
   Web of Science ®Google Scholar
• Zheng B, Ozen Z, Zhang X, De Silva S, Marinova E, Guo L, Wansley D, Huston DP, West MR, Han S. 2005. CXCL13 neutralization reduces the severity of collagen-induced arthritis. Arthritis Rheum 52:620–626.
   Google Scholar
• Zhou Y, Kurihara T, Ryseck RP, Yang Y, Ryan C, Loy J, Warr G, Bravo R. 1998. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 160: 4018–4025.
   PubMed Web of Science ®Google Scholar
• Zlotnik A. 2006. Chemokines and cancer. Int J Cancer 119:2026–2029.
   PubMedGoogle Scholar
• Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:21–26.
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Morales J, Hedrick JA. 1999. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19:1–47.
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Yoshie O, Nomiyama H. 2006. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:1–11.
   PubMed Web of Science ®Google Scholar